|
Research Interests
Dr. Muly received his M.D. in 1993,
his Ph.D. in 1992 from Duke University and his residency training in
psychiatry at Yale University. He was trained in the laboratories of David
Fitzpatrick and Patricia Goldman-Rakic. His research activities are
currently focused on elucidating the structural basis for cortical
function. Neuroanatomical techniques, including electron
microscopic approaches and immunohistochemistry, are utilized by
Dr. Muly to relate the circuitry of the prefrontal cortex to the
molecular machinery of neurotransmission. He is currently examining
the D1 receptor and its signal transduction proteins
(protein phosphatase-1 alpha and -1gamma1). He is presently funded
by the National Science Foundation (NSF) on a joint project with
Dr. Martha Bickford and Dr. Paul J. May entitled “Synaptic
Organization of the Primate Pulvinar Nucleus”. In addition to
maintaining an active research laboratory, Dr. Muly devotes a
significant amount of time to his clinical practice. Although his
scientific work has focused on issues relevant to schizophrenia,
his clinical practice is with a population of patients with a broad
range of diagnoses. Dr. Muly's research is funded by grants from
the National Institute of Mental
Health, NARSAD Young
Investigator Award, and the Stanley Foundation
(SMRI).
Selected Publications
Muly, III, E.C., Greengard,
P. and Goldman-Rakic, P.S.: Distribution of protein phosphatases- 1
alpha and -1gamma1 and the D1 receptor in primate
prefrontal cortex: evidence for discrete populations of spines.
Journal of Comparative Neurology, 440: 261-70,
2001.
Goldman-Rakic,
P.S., Muly, III, E.C. and Williams, G.V.: D1
receptors in prefrontal cells and circuits. Brain Research-Brain
Research Reviews, 31: 295-301, 2000.
Krimer, L.S.,
Muly, III, E.C. and Williams, G.V.: Dopaminergic
regulation of cerebral cortical microcirculation. Nature
Neuroscience, 1: 286-9, 1998.
Muly, III,
E.C., Szigeti, K. and Goldman-Rakic, P.S.: D1 receptor in
interneurons of macaque prefrontal cortex: Distribution and
subcellular localization. Journal of Neuroscience, 18:
10553-65, 1998.
Muly, III, E.C., Signal transduction abnormalities in
schizophrenia: The Camp System. Psychopharmacology Bulletin,
36:92-105, 2002.
Muly, III, E.C., Maddox, M. and Smith, Y.: Distribution of
mGluR1a and mGluR5 immunolabeling in primate prefrontal cortex.
J. Comp. Neurol., 467:521-535, 2003.
Waugh, J.L., Lou, A.C., Eisch,
A.J., Monteggia, L.M., Muly,E.C. Gold, S.J.: Regional, cellular and subcellular
localization of RGS10 in rodent brain. J Comp
Neurol. (in press)
Muly, E. C., Allen, P., Mazloom,
M., Aranbayeva, Z.,
Greenfield, A.T., Greengard, P.: Subcellular
distribution of neurabin immunolabeling in primate prefrontal
cortex: Comparison with spinophilin. Cerebral Cortex
(in press)
Muly, E. C., Smith, Y., Allen, P.,
Greengard, P.: Subcellular distribution of spinophilin
immunolabeling in primate prefrontal cortex:Localization to and
within dendritic spines. J. Comp. Neurol.,
469:185-197, 2004.
|